Delhi reports first Covid JN.1 case

Published On 2023-12-29 11:51 GMT   |   Update On 2023-12-29 11:51 GMT
Advertisement

Following the identification of the first case of the Covid-19 sub-variant JN.1 in the national capital, the All India Institute of Medical Sciences (AIIMS) in Delhi has released guidelines for managing suspected or positive Covid patients in hospitals. In response to a meeting with department heads, the AIIMS Delhi Director has directed the establishment of a Covid screening Outpatient Department (OPD) within the emergency department. Additionally, 12 beds in a designated ward will be reserved for the hospitalization of critically ill patients. AIIMS Delhi has also mandated Covid testing for individuals exhibiting Severe Acute Respiratory Infections (SARI) symptoms.

Advertisement

The directives include the allocation of Covid management provisions in all AIIMS departments and the earmarking of specific beds for serious cases. A screening OPD in the Emergency Department will assess patients for Covid-like symptoms, and a new private ward will accommodate Covid-positive Employees Health Scheme (EHS) beneficiaries. Furthermore, the installation of advanced air purifying filters is underway.

For more news & updates, check out the link given below:

https://medicaldialogues.in/

Full View
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News